Detalhe da pesquisa
1.
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
Vaccines (Basel)
; 12(2)2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400124
2.
Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Virol J
; 10: 6, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23282186
3.
Crimean-Congo Hemorrhagic Fever Virus: Progress in Vaccine Development.
Diagnostics (Basel)
; 13(16)2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627967
4.
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
Front Plant Sci
; 14: 1202570, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600182
5.
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.
Front Plant Sci
; 14: 1290042, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38034565
6.
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Vaccine
; 41(2): 380-390, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460536
7.
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
Vaccines (Basel)
; 11(7)2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515050
8.
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.
Vaccines (Basel)
; 10(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366373
9.
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Hum Vaccin Immunother
; 18(6): 2122503, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315843
10.
A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™).
Front Immunol
; 13: 963309, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439138
11.
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
Front Immunol
; 13: 824378, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35401544
12.
Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection.
Heliyon
; 7(10): e08161, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34703927
13.
Development of an Inactivated Vaccine against SARS CoV-2.
Vaccines (Basel)
; 9(11)2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835197
14.
Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).
PLoS Negl Trop Dis
; 15(12): e0009973, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851958
15.
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19.
Vaccines (Basel)
; 9(11)2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835268
16.
Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.
Sci Rep
; 11(1): 5936, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723328
17.
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
Viruses
; 13(8)2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452461
18.
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
PLoS Negl Trop Dis
; 14(11): e0008834, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33226988
19.
Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
PLoS One
; 15(9): e0238614, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936826
20.
Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats.
Turkiye Parazitol Derg
; 42(1): 39-80, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29780018